RoviCM's Current FDA Situation
25 May 2006 14:09
One of the priorities of RoviCM is to comply with the FDA regulation, as part of the quality standards system. The project is being directed by an ex-FDA inspector in parenterals as well as by known external companies. FDA inspection should be during the second quarter of 2006.
For more information on this company:
ROVI - Aseptic Filling of Small Volume Parenterals
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
